Products You May Like
A day after announcing differential pricing for the Covid-19 vaccine Covishield for the central and state governments, Serum Institute of India (SII) CEO Adar Poonawalla said on Thursday that there will be no differential pricing. The central government will also have to pay Rs 400 per dose from now on.
In response to the criticism for offering the Covishield vaccine at Rs 150 to the central government and at Rs 400 to state governments, Poonawalla said his company would charge Rs 400 per dose to any government.
SII’s price of Rs 150 to the central government was for prior commitments and contracts. SII has already suppled 10 crore doses to the central government and these have been administered. It signed a new contract in March to supply another 11 crore doses, which the company will start delivering this month. After supplying these, the vaccine maker will negotiate a fresh contract at the new price of Rs 400, if the Centre decides to buy any more doses from them, Poonawalla said.
SII had on Wednesday announced that state governments will get the vaccine at Rs 400 per dose and private hospitals at Rs 600 per dose.
As per the country’s new vaccine strategy, vaccination will be open to all adults from May 1.
SII will be able to supply 50% of the Covishield production to state governments and private hospitals and the rest to the central government.
India’s cumulative vaccination coverage as on Thursday was 13.23 crore doses, with Covishield accounting for around 90% of the shots administered so far.
Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.
Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.